Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fey

Showing results (221-230 of 271) with videos related to

Pageof 28
Sort By:
European Journal of Haematology|October 1, 1990
Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemiaM F Fey, A Tobler, B Stadelmann, et al.
Annals of Hematology|December 24, 1997
MTS1 expression and prognosis in acute myeloid leukemiaC F Rochlitz, A Lohri, G Sasse-Roth, et al.
British Journal of Cancer|October 13, 2006
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapiesS Leyvraz, R Herrmann, L Guillou, et al.
Blood|April 28, 2005
CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)Daniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
British Journal of Haematology|December 31, 1997
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, S F Hsu Schmitz, D Ratschiller, et al.
Molecular Cancer Research : MCR|June 4, 2009
The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1Mathias Jenal, Emmanuelle Trinh, Christian Britschgi, et al.
British Journal of Haematology|May 1, 1994
Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. Working Party on Leukaemia of the Swiss Group for Epidemiologic and Clinical Cancer Research (SAKK)M Wernli, A Tichelli, V von Fliedner, et al.
Schweizerische Medizinische Wochenschrift|February 9, 1991
[The treatment of acute lymphatic leukemia in adults: pilot project with intensive early therapy without a maintenance phase]M Wernli, A Gratwohl, V von Fliedner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK)M M Borner, M Castiglione, M Bacchi, et al.
Oncogene|November 23, 2005
Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1C Britschgi, M Rizzi, T J Grob, et al.
Pageof 28

Showing results (221-230 of 271) with videos related to

Sort By:
Pageof 28
European Journal of Haematology|October 1, 1990
Immunogenotyping with antigen receptor gene probes as a diagnostic tool in childhood acute lymphoblastic leukaemiaM F Fey, A Tobler, B Stadelmann, et al.
Annals of Hematology|December 24, 1997
MTS1 expression and prognosis in acute myeloid leukemiaC F Rochlitz, A Lohri, G Sasse-Roth, et al.
British Journal of Cancer|October 13, 2006
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapiesS Leyvraz, R Herrmann, L Guillou, et al.
Blood|April 28, 2005
CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16)Daniel Helbling, Beatrice U Mueller, Nikolai A Timchenko, et al.
British Journal of Haematology|December 31, 1997
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, S F Hsu Schmitz, D Ratschiller, et al.
Molecular Cancer Research : MCR|June 4, 2009
The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1Mathias Jenal, Emmanuelle Trinh, Christian Britschgi, et al.
British Journal of Haematology|May 1, 1994
Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. Working Party on Leukaemia of the Swiss Group for Epidemiologic and Clinical Cancer Research (SAKK)M Wernli, A Tichelli, V von Fliedner, et al.
Schweizerische Medizinische Wochenschrift|February 9, 1991
[The treatment of acute lymphatic leukemia in adults: pilot project with intensive early therapy without a maintenance phase]M Wernli, A Gratwohl, V von Fliedner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK)M M Borner, M Castiglione, M Bacchi, et al.
Oncogene|November 23, 2005
Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1C Britschgi, M Rizzi, T J Grob, et al.
Pageof 28